Breast Cancer - HER2 Positive Clinical Trials

A listing of Breast Cancer - HER2 Positive medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study of ONT-380, Capecitabine, Trastuzumab and Placebo to evaluate HER2 Positive Breast Cancer

Mobile Alabama 36608

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

Mobile Alabama 36604

Patients are needed to participate in a clinical research study of ONT-380, Capecitabine, Trastuzumab and Placebo to evaluate HER2 Positive Breast Cancer

Arizona

Chandler Arizona 85224

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

Gilbert Arizona 85234

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

Goodyear Arizona 85338

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

California

Anaheim California 92801

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

Bakersfield California 93309

A Phase 2 clinical study for patients with Hormone Receptor Positive Tumor or HER-2 Positive Breast Cancer

Burbank California 91505

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

Fullerton California 92835

A Phase 2 clinical study for patients with Hormone Receptor Positive Tumor or HER-2 Positive Breast Cancer

Long Beach California 90806

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

View More ▼

Los Angeles California 90033

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

Los Angeles California 90024

A Phase 2 clinical study for patients with Hormone Receptor Positive Tumor or HER-2 Positive Breast Cancer

Los Angeles California 90095

A Phase 2 clinical study for patients with Hormone Receptor Positive Tumor or HER-2 Positive Breast Cancer

Los Angeles California 90095

Patients are needed to participate in a clinical research study of ONT-380, Capecitabine, Trastuzumab and Placebo to evaluate HER2 Positive Breast Cancer

Redondo Beach California 90277

A Phase 2 clinical study for patients with Hormone Receptor Positive Tumor or HER-2 Positive Breast Cancer

Sacramento California 95817

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

San Diego California 92123

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

San Francisco California 94115

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

San Francisco California 94115

Patients are needed to participate in a clinical research study of ONT-380, Capecitabine, Trastuzumab and Placebo to evaluate HER2 Positive Breast Cancer

Santa Maria California 93454

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

Santa Monica California 93454

A Phase 2 clinical study for patients with Hormone Receptor Positive Tumor or HER-2 Positive Breast Cancer

Stanford California 94305

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

Vallejo California 94589

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

Vallejo California 94589

Patients are needed to participate in a clinical research study of ONT-380, Capecitabine, Trastuzumab and Placebo to evaluate HER2 Positive Breast Cancer

Colorado

Aurora Colorado 80045

Patients are needed to participate in a clinical research study of ONT-380, Capecitabine, Trastuzumab and Placebo to evaluate HER2 Positive Breast Cancer

Englewood Colorado 80112

A Phase 2 clinical study for patients with Hormone Receptor Positive Tumor or HER-2 Positive Breast Cancer

Fort Collins Colorado 80528

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

Connecticut

Bridgeport Connecticut 06610

Patients are needed to participate in a clinical research study of Rapamycin and Trastuzumab to evaluate Breast Cancer

New Haven Connecticut 06511

Patients are needed to participate in a clinical research study of ONT-380, Capecitabine, Trastuzumab and Placebo to evaluate HER2 Positive Breast Cancer

New Haven Connecticut 06519

Patients are needed to participate in a clinical research study of Rapamycin and Trastuzumab to evaluate Breast Cancer

Stamford Connecticut 06904

Patients are needed to participate in a clinical research study of ONT-380, Capecitabine, Trastuzumab and Placebo to evaluate HER2 Positive Breast Cancer

District of Columbia

Washington District of Columbia 20010

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

Washington District of Columbia 20010

Patients are needed to participate in a clinical research study evaluating Trastuzumab, Pertuzumab, Ado-trastuzumab emtansine for the treatment of HER2 Positive Breast Cancer or Left Ventricular Function Systolic Dysfunction

Washington District of Columbia 20057

Patients are needed to participate in a clinical research study evaluating Trastuzumab, Pertuzumab, Ado-trastuzumab emtansine for the treatment of HER2 Positive Breast Cancer or Left Ventricular Function Systolic Dysfunction

Florida

Fort Myers Florida 33916

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

Fort Myers Florida 33908

A Phase 2 clinical study for patients with Hormone Receptor Positive Tumor or HER-2 Positive Breast Cancer

Fort Myers Florida 33916

Patients are needed to participate in a clinical research study of ONT-380, Capecitabine, Trastuzumab and Placebo to evaluate HER2 Positive Breast Cancer

Hollywood Florida 33021

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

Miami Beach Florida 33140

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

View More ▼

Miami Beach Florida 33140

Patients are needed to participate in a clinical research study of ONT-380, Capecitabine, Trastuzumab and Placebo to evaluate HER2 Positive Breast Cancer

New Port Richey Florida 34655

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

Orlando Florida 32806

A Phase 2 clinical study for patients with Hormone Receptor Positive Tumor or HER-2 Positive Breast Cancer

Plantation Florida 33324

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

Plantation Florida 33324

A Phase 2 clinical study for patients with Hormone Receptor Positive Tumor or HER-2 Positive Breast Cancer

Plantation Florida 33324

Patients are needed to participate in a clinical research study of ONT-380, Capecitabine, Trastuzumab and Placebo to evaluate HER2 Positive Breast Cancer

Plantation Florida 33324

Patients are needed to participate in a clinical research study of ONT-380, Capecitabine, Trastuzumab and Placebo to evaluate HER2 Positive Breast Cancer

Port St. Lucie Florida 34952

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

St. Petersburg Florida 33705

A Phase 2 clinical study for patients with Hormone Receptor Positive Tumor or HER-2 Positive Breast Cancer

St. Petersburg Florida 33705

Patients are needed to participate in a clinical research study of ONT-380, Capecitabine, Trastuzumab and Placebo to evaluate HER2 Positive Breast Cancer